Longitudinal risk of herpes simplex virus (HSV) type 1, HSV type 2, and cytomegalovirus infections among young adolescent girls

Clinical Infectious Diseases

Volumn 39, Issue 10, 2004, Pages 1433-1438

  Stanberry, Lawrence R ^a,c   Rosenthal, Susan L ^a,c   Mills, Lisa ^a   Succop, Paul A ^a   Biro, Frank M ^a   Morrow, Rhoda Ashley ^b   Bernstein, David I ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERPES SIMPLEX VIRUS 1 ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADOLESCENT; ANTIBODY DETECTION; ARTICLE; COHORT ANALYSIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FEMALE; GENITAL HERPES; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; INFECTION RISK; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; SEROPREVALENCE; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE;

ADOLESCENT; CHILD; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HERPES GENITALIS; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; LONGITUDINAL STUDIES; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; URBAN POPULATION;

EID: 8744227150     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/425307     Document Type: Article

References (29)

1. Evans AS, Kaslow RA. Viral infections of humans: epidemiology and control. 4th ed. New York: Plenum Medical Book Company, 1997.
2. Stanberry LR, Rosenthal SL. The epidemiology of herpes simplex virus infections in adolescents. Herpes 1999; 6:12-5.
3. Plotkin SA. Vaccination against cytomegalovirus. Arch Virol Suppl 2001; 17:121-34.
4. Stanberry LR, Cunningham AL, Mindel A, et al. Prospects for control of herpes simplex virus disease through immunization. Clin Infect Dis 2000; 30:549-66.
5. Bernstein DE, Schleiss MR, Berencsi K, et al. Effect of previous or simultaneous immunization with canarypox expressing cytomegalovirus (CMV) glycoprotein B (gB) on response to subunit gB vaccine plus MF59 in healthy CMV-seronegative adults. J Infect Dis 2002; 185: 686-90.
6. Fleming DT, McQuillan GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997; 337: 1105-11.
7. Gottlieb SL, Douglas JM Jr, Schmid DS, et al. Seroprevalence and correlates of herpes simplex virus type 2 infection in five sexually transmitted-disease clinics. J Infect Dis 2002; 186:1381-9.
8. Crosby RA, DiClemente RJ, Wingood GM, Rose E. Testing for HSV-2 infection among pregnant teens: implications for clinical practice. J Pediatr Adolesc Gynecol 2003; 16:39-41.
9. Sucato G, Celum C, Dithmer D, Asley R, Wald A. Demographic rather than behavioral risk factors predict herpes simplex virus type 2 infection in sexually active adolescents. Pediatr Infect Dis J 2001; 20:422-6.
10. Rosenthal SL, Lewis LM, Succop PA, Burklow KA, Biro FM. Adolescent girls' perceived prevalence of sexually transmitted diseases and condom use. J Dev Behav Pediatr 1997; 18:158-61.
11. Rosenthal SL, Stanberry LR, Biro FM, et al. Seroprevalence of herpes simplex virus types 1 and 2 and cytomegalovirus in adolescents. Clin Infect Dis 1997; 24:135-9.
12. Ashley RL, Militoni J, Lee F, Nahmias A, Corey L. Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J Clin Microbiol 1988; 26:662-7.
13. Bernstein DI, Garraty E, Lovett MA, Bryson YJ. Comparison of Western blot analysis to microneutralization for the detection of type-specific herpes simplex virus antibodies. J Med Virol 1985; 15:223-30.
14. Sohn YM, Oh MK, Balcarek KB, Cloud GA, Pass RF. Cytomegalovirus infection in sexually active adolescents. J Infect Dis 1991; 163:460-3.
15. SAS/STAT user's guide. Version 6, 4th ed. Gary, NC: SAS Institute, 1989.
16. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear model. Biometrics 1986; 73:13-22.
17. Corey L, Langenberg AG, Ashley R, et al. Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. JAMA 1999; 282:331-40.
18. Langenberg A, Benedetti J, Jenkins J, Ashley R, Winter C, Corey L. Development of clinically recognizable genital lesions among women previously identified as having "asymptomatic" herpes simplex virus type 2 infection. Ann Intern Med 1989; 110:882-7.
19. Langenberg AG, Corey L, Ashley RL, Leong WP, Straus SE. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N Engl J Med 1999; 341: 1432-8.
20. Mertz GJ, Ashley R, Burke RL, et al. Double-blind, placebo-controlled trial of a herpes simplex virus type 2 glycoprotein vaccine in persons at high risk for genital herpes infection. J Infect Dis 1990; 161:653-60.
21. Bryson Y, Dillon M, Bernstein DI, et al. Risk of acquisition of genital herpes simplex virus type 2 in sex partners of persons with genital herpes: a prospective couple study. J Infect Dis 1993; 167:942-6.
22. Stanberry LR, Spruance SL, Cunningham AL, et al. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med 2002; 347:1652-61.
23. Xu F, Schillinger IA, Sternberg MR, et al. Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988-1994. J Infect Dis 2002; 185:1019-24.
24. Brown ZA, Selke S, Zeh J, et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997; 337:509-15,
25. Whitacre CC, Reingold SD, O'Looney PA, et al. A gender gap in autoimmunity. Science 1999; 283:1277-8.
26. Cherpes TL, Meyn LA, Krohn MA, Lurie JG, Hillier SL, Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clin Infect Dis 2003; 37:319-25.
27. Lewis LM, Bernstein DI, Rosenthal SL, Stanberry LR. Seroprevalence of herpes simplex virus-type 2 in African-American college women. J Natl Med Assoc 1999; 91:210-2.
28. Bunnell RE, Dahlberg L, Rolfs R, et al. High prevalence and incidence of sexually transmitted diseases in urban adolescent females despite moderate risk behaviors, J Infect Dis 1999; 180:1624-31.
29. Ellen JM, Aral SO, Madger LS. Do differences in sexual behaviors account for the racial/ethnic differences in adolescents' self-reported history of a sexually transmitted disease? Sex Transm Dis 1998; 25: 125-9.